Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

LONDON, October 7 /PRNewswire/ -- Fiat and AKQA have developed eco:Drive. A motor and technology first for linking drivers with in-car telemetry - improving fuel efficiency and reducing CO2 emissions.

eco:Drive is the very latest in digital integrated technology. It is an easy-to-use computer application that connects your car to your PC. Using cutting-edge analytic software, eco:Drive dissects and evaluates your driving style and shows you ways to cut down on fuel consumption, reducing your CO2 emissions and saving you money. In fact, with consistent use of the application, you can expect to reduce your CO2 emissions by up to 15 per cent.

LONDON, October 10 /PRNewswire/ --

Platts -- The 13 members of the Organization of the Petroleum Exporting Countries (OPEC) pumped an average 32.47 million barrels per day (b/d) of crude oil in September, a Platts survey of OPEC and oil industry officials showed today. This is down 330,000 barrels per day from August and reflects output declines in Saudi Arabia, Iraq and Angola.

Excluding Iraq, the 12 members bound by production agreements produced an average 30.18 million b/d, the survey showed. This is 230,000 b/d less than the August output of 30.41 million b/d and exceeds the so-called OPEC-12 output target of 29.673 million b/d by 507,000 b/d.

DALLAS, October 10 /PRNewswire/ --

- Recent Expansion Follows US$20 M Intel Capital Funding

Despite the turmoil surrounding the nation's economy, Telligent today announced the opening of a new office in London, England. Along with the new international headquarters comes the announcement of domestic expansion.

Telligent, an innovative social software and solutions company headquartered in Dallas, recently received US$20 million in funding from Intel Capital and has started growing its sales team and global reach.

LONDON, October 10 /PRNewswire/ -- Greenstar UK, the fast-growing recycling-led waste management company, is to build one of the capital's largest materials recycling facilities (MRFs) which will process nearly 10% of north London's waste. It has acquired the 192,000 ft squared Atlas warehouse building, purpose-built on a nine acre site next to the Edmonton refuse incinerator.

Adjacent to major transport links such as the North Circular and the M25, the site will be fitted out with the most modern technology for the high quality processing of recyclable materials. It will also be a depot for up to 60 recycling vehicles which will collect commercial recyclables.

SANTA CLARA, California, October 10 /PRNewswire/ --

Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement and control solutions for life science process applications, announced the release of version 3.4 of its TruBio bioreactor control software. TruBio 3.4 software can automate bioreactors across a wide variety of applications, ranging from 1L bench top R&D glass to 1000L cGMP production single-use vessels. TruBio 3.4 software is optimized for DeltaV version 9.3 from Emerson Process Management in order to bring ease of use and reliability to the user.

COPENHAGEN, Denmark, October 10 /PRNewswire/ --

- Summary: Genmab has Reached the Sixth Milestone in its Ofatumumab Collaboration With GSK

Genmab A/S (OMX: GEN) announced today it has reached the sixth milestone for ofatumumab (HuMax-CD20(R)) under the terms of its collaboration with GlaxoSmithKline (GSK). A milestone payment of approximately DKK 29 million (approximately USD 5.6 million) was triggered by the first patient receiving treatment in the ofatumumab Phase I study in relapsed/refractory follicular non-Hodgkin's lymphoma and chronic lymphocytic leukemia in Japan.